Results 81 to 90 of about 596,709 (351)
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance
Current Oncology, 2022 The development and approval of ruxolitinib, the first JAK1/2 inhibitor indicated to treat myelofibrosis, has improved patient outcomes, with higher spleen and symptoms responses, improved quality of life, and overall survival.Massimo Breccia, Francesca Palandri, Paola Guglielmelli, Giuseppe Alberto Palumbo, Alessandra Malato, Francesco Mendicino, Alessandra Ricco, Emanuela Sant’Antonio, Mario Tiribelli, Alessandra Iurlo +9 moredoaj +1 more sourceClinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease
Arthritis Care &Research, EarlyView.Objective
Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.Anahita Deboo, Robert Fox, Katherine M. Hammitt, Julie Frantsve‐Hawley, Matthew C. Baker, Stamatina Danielides, Eduardo De Sousa, Brent P. Goodman, Jennifer K. King, Steven Mandel, Ghaith Noaiseh, Pantelis P. Pavlakis, George Sarka, R. Hal Scofield, Arun Varadhachary, Daniel J. Wallace, Matt Makara, Nancy Carteron, Steven Carsons, in collaboration with the Consensus Expert Panel (CEP) members, G. Alden Adkins, Brittany Adler, Hossein Ansari, Senada Arabelovic, Alan Baer, Denis Balaban, Shamik Bhattacharyya, Evelyn Bromet, Krishna Chaganti, Kamal Chemali, Melissa Cortez, Schartess Culpepper, Paul Dellaripa, Dana Direnzo, Daniel El Bogdadi, Robert Fearon, Mehrnez Fischbach, Judi Furlong, Christopher Gibbons, Rachael Gordon, Thomas Grader Beck, Syed Haider, Larry Hollenbeck, Chadwick R. Johr, Stuart S. Kassan, Brian King, Octavia Kincaid, Eugene Kissin, Vasileios Kyttaris, Lindsay Lally, Brandon M. Law, Janet Lewis, Scott M. Lieberman, Amanda Lusa, Joseph Lutt, Rashmi Maganti, Arthur M. Mandelin, Sara McCoy, Kerry Neall, Timothy Niewold, Anne Louise Oaklander, Ruben A. Peredo‐Wende, Lynn Petruzzi, Mark A. Porter, Guada Respicio Duque, Tania Reyna, Nathaniel M. Robbins, Elliot D. Rosenstein, Laura Rosow, Breanna Ruthrauff, Amit Sachdev, Nora Sandorfi, Sarah Schafer, Elena Schiopu, Chokkalingam Siva, Daniel Small, Sara M. Stern, Lauren Stiles, Susan Stoddard, Jinny Tavee, Donald Thomas, Edward L. Treadwell, Nagagopal Venna, Steven Vernino, Frederick B. Vivino, Brittany Weber, Sepideh Yadollahi, Huiying Yu, Scott Zashin +88 morewiley +1 more sourceHereditary fructose intolerance
Definitions, 2020 Hereditary fructose intolerance is a condition that affects a person's ability to digest the sugar fructose. Fructose is a simple sugar found primarily in fruits.D. Metze, V. F. Cury, Ricardo S. Gomez, L. Marco, Dror Robinson, Eitan Melamed, Alexander K. C. Leung, Jae-Hwan Nam, Yoichi Matsubara, Keiya Tada, S. Sancak, R. Paschke, S. Kupka, Stefan K. Plontke, H. Zenner, G. Azhar, Jeanne Y. Wei, Y. Kang, Katsuhiko Yoshizawa, Abraham Nyska, Graeme Jones, K. Triantafilou, P. Lepper, J. Bode, C. Kashtan, Klaus Schümann, Günter Weiss, C. Skerka, Christoph Licht, P. Zipfel, Hugo ten Cate, M. Oette, D. Häussinger, Isabelle Ruel, P. Couture, B. Lamarche, S. Siegmund, Stephan L. Haas, Manfred V. Singer, T. Heintges, R. Kubitz, A. Erhardt, F. Lammert, J. Lorenzen, Hubert E. Blum, Darius Moradpour, Georg H. Merker, M. Wettstein, Mónica Guevara, Pere Ginés, Hugo ten Cate, Ulrich Heininger, Markus Pfister, M. Schmitt, A. Schinkel, D. Poldermans, Jeroen J. Bax, H. Mairbäurl, P. Bärtsch, Georg H. Merker, Percy Chiu, R. Legro, W. Nyhan, Sandeep S. Dave, Jürgen Kohlhase, A. Dielis, S. Harvey Mudd, Christian Simon, Oliver Schildgen, S. L. Sternak, G. Mlinarić‐Galinović, Eggert Stockfleth, I. Nindl, Inga Zerr, Mathias Bähr, N. Stankus, K. Lindenberg, G. Bernhard Landwehrmeyer, Jonas Denecke, S. Katsuragi, B. Grimbacher, C. Woellner, Steven Holland, Christian Bender Koch, Michael T. Geraghty, Peter L. M. Jansen, Robert P. Whitehead, Edward M. Brown, Mei Bai, T. Martin, Joaquin Escribano, Victor M. Garca Nieto, Patrick T. S. Ma, Lucia K. Ma, Alexander K. C. Leung, Angelika F. Hahn, M. Nallegowda, Upinderpal Singh, M. Umapathi, Rakesh Kumar, R. Badolato, Benjamin Glaser, R. Schreiber, Daniel Landau, Goo Taeg Oh, C. Kallen, J. Topf, Patrick Murray, Jaime Tejedor, Manish Kumar Varshney, K. Suphapeetiporn, V. Shotelersuk, Bernd Hoppe, Albrecht Hesse, Geoffrey N. Hendy, David E. C. Cole, Charles R. Nolan, H. Shintaku, Hiroshi Ichinose, Henry J. Mankin, G. Uwaifo, Bettina C. Reulecke, Werner Heppt, A. Cryer, Radoslav Tomić, Jesse Roman, J. Rémi, S. Noachtar, M. Nagase, Toshiro Fujita, Á. Cogolludo, Jason X.-J. Yuan, Lewis J. Rubin, Manning R. Davis, T. Poduval, Saurabh Chatterjee, H. Gozu, M. Eszlinger, R. Bircan, J. Lüblinghoff, Julia Lüblighoff, Roland Pfäffle, S. Zhao, Hui-jun Ye, J. Mogensen, R. Kebudi, Sezer Saglam, Michael A. Becker, J. Asplin, R. Gotshall, H. Scharnagl, W. März, J. A. Sayer, Simon H.S. Pearce, James Paparello, P. Klemmer, Abhijit V. Kshirsagar, Patrick T. S. Ma, Lucia K. Ma, Marco Castori, R. Siener, P. Habermehl, M. Knuf, Christoph Michalski, J. Kleeff, Annette Richter-Unruh, D. Headon, P. Overbeek, Alanna F. Bree, Hendrica Belge, E. Riveira-Muñoz, O. Devuyst, Stefanie Weber, M. Moritz, J. Ayus, Simon H.S. Pearce, Michael P. Whyte, Masafumi Fukagawa, Motoko Tanaka, H. Tenenhouse, A. Gutenberg, Patrizio Caturegli, C. Oswalt, P. Eghtesady, M. Suneja, Christie P. Thomas, H. Sasaki, T. Yukioka, M. V. van Steensel, R. Wu, Ping Wang, G. Feuerstein, R. Ruffolo, H. Jinnah, James C. Harris, Holger K. Eltzschig, A. Grenz +196 moresemanticscholar +1 more sourceFrom exercise intolerance to functional improvement: The second wind phenomenon in the identification of McArdle disease [PDF]
, 2014 McArdle disease is the most common of the glycogen storage diseases. Onset of symptoms is usually in childhood with muscle pain and restricted exercise capacity.Andrea Beggs, Andreu AL, Andrew Wakelin, Borg G, Braakhekke JP, Charlotte Ellerton, Gurgel-Giannetti J, Haller RG, Janice L Holton, Jatin Pattni, Lucia A, Lucia A, Miteff F, Nadaj-Pakleza AA, Pearson C, Pernow BB, Quinlivan R, Renata Siciliani Scalco, Richard Godfrey, Ros Quinlivan, Sherryl Chatfield, Stefen Brady, Vieitez I, Vissing J +23 morecore +3 more sourcesEfficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
Arthritis & Rheumatology, 2019 To investigate the efficacy and safety of ixekizumab in patients with active radiographic axial spondyloarthritis (SpA) and prior inadequate response to or intolerance of 1 or 2 tumor necrosis factor inhibitors (TNFi).A. Deodhar, D. Poddubnyy, C. Pacheco-Tena, C. Salvarani, E. Lespessailles, P. Rahman, P. Järvinen, J. Sánchez-Bursón, K. Gaffney, E. Lee, E. Krishnan, Silvia Santisteban, Xiaoqi Li, F. Zhao, H. Carlier, J. Reveille +15 moresemanticscholar +1 more sourceBench‐to‐Bedside Translation of Self‐Healing Colloidal Hydrogels as Next Generation Design of Flowable Hemostatic Matrix: From Preclinical Evaluation to Human Clinical Trials
Advanced Science, EarlyView.ABSTRACT
Self‐healing materials represent a paradigm shift in designing functional biomedical devices for drug delivery, tissue regeneration, and 3D bioprinting. However, their clinical translation remains limited by challenges such as insufficient mechanical strength, potential cytotoxicity from chemical modifications, and complex activation ...Ganjun Feng, Kaiwen Chen, Qiwei Ying, Shuya Wang, Xin Li, Guanlin Li, Yantao Zhao, Binghua Ma, Huanan Wang, Dawei Li, Lijun Zhang, Jian Zhang, Yu Zhao, Changle Ren, Baodong Chen, Yueming Song +15 morewiley +1 more sourceFully Humanized Bispecific T Cell Engager Shows Potent Activity in Central Nervous System and Peripheral Tumors
Advanced Science, EarlyView.This study reports the development of a fully humanized bispecific T cell engager targeting IL13RA2, a tumor‐associated antigen enriched in glioblastoma. This off‐the‐shelf immunotherapy drives potent, antigen‐dependent T cell activation and tumor killing, and prolongs survival in experimental GBM and other solid tumors models without detectable off ...Joseph T. Duffy, Angela Martin‐Regalado, Benedikt E. Haupt, Jacob R. Pogue, Aditi Thakur, Manuel Fierro Cota, Markella Zannikou, Sol Misener, Vera P. Krymskaya, Kathleen McCortney, Jason Miska, Craig Horbinski, Dmitri Simberg, Maciej S. Lesniak, Charles D. James, Roger Stupp, Irina V. Balyasnikova +16 morewiley +1 more source